On Monday, June 6, another meeting of the Transparency Council.
The guest of Medexpress is prof. Monika Adamczyk-Sowa, president of the Multiple Sclerosis and Neuroimmunology Section of the PTN.
Folded in May this year. by National Medicines Manufacturers to the European Parliament, a petition to support the production of ingredients for the production of drugs in the EU was approved and will be considered in the fall of this year.
On May 30 (Monday) another meeting of the Transparency Council.
On May 23 (Monday) another meeting of the Transparency Council.
We publish the position of the Polish Society of Rheumatology on the availability of innovative therapies for patients with rheumatic diseases
On May 9 (Monday) another meeting of the Transparency Council.
The Main Pharmaceutical Inspector decided to suspend the national market of the medicinal product: Sumilar HCT (Ramiprilum + Amlodipinum + Hydrochlorothiazidum), 5 mg + 5 mg + 12.5 mg, hard capsules batch number: 12574261 expiry date: 04.2023 . The responsible party is Sandoz GmbH,...
The May reimbursement list included two highly anticipated treatments: polatuzumab vedotin and Car-T for patients with refractory and relapsed B-cell lymphoma who had no previous treatment options.
On April 25 (Monday) another meeting of the Transparency Council.
The European Commission approves the use of abemaciclib in combination with endocrine therapy for the adjuvant treatment of adult patients with hormone receptor-positive (HR) early stage breast cancer and non-expressing human epidermal growth factor receptor 2 (HER2) type 2 receptor with lymph...
French biotechnology company Medesis Pharma has asked the Defense Innovation Agency for funds to accelerate the development of three drugs for mass use in different scenarios of nuclear contamination of the population. The three experimental drugs are designed to treat large populations that have...
What is the Transparency Council going to do on April 4?
The Medical Research Agency has launched a competition dedicated to entrepreneurs for financing the development, performance and clinical evaluation of innovative medical devices, for which it will allocate PLN 100 million. The call for applications lasts from March 30, 2022 to June 30, 2022.
Google has some plans for us. The company wants to use smartphones to monitor health - it will record the rhythm of the heartbeat and look ... deep into our eyes. This is to help you recognize health problems.
Prostate cancer is the most common oncological disease among men in Poland. Every year, this disease affects nearly 16,000 men, of which as many as of them die. The detection of prostate neoplasms is relatively easy. For diagnostics, only blood tests and a visit to the urologist are necessary. To...
What will the Transparency Council do on March 21?
The Chief Sanitary Inspector issued a decision on the nationwide recall of the medicinal product: Vigantol (Cholecalciferolum), 500 µg/ml (20,000IU/ml), oral drops, solution, lot number 19KQ193, expiry 10.2024. The responsible entity is P&G Health Germany GmbH. The decision was made immediately...
Two pharmaceutical companies, Pfizer and Bayer, have confirmed that they will keep humanitarian drug deliveries to Russia, but will withdraw from other activities in the country.
Domestic pharmaceutical companies associated in the Polish Association of Pharmaceutical Industry Employers donated almost one million drug packages to Ukraine, worth approximately PLN 15 million.
In view of the ongoing Russian invasion of Ukraine and the influx of refugees, we need to find systemic solutions as soon as possible to legally and efficiently provide these people with medical care. An essential element is ensuring access to drugs. As an industry, we declare the willingness to...
Janssen - the pharmaceutical company Johnson & Johnson - has signed a cooperation agreement with the Warsaw Health Innovation Hub.
The health department published: Announcement of the Minister of Health of February 21, 2022 on the list of drugs and foodstuffs for particular nutritional uses for which an official selling price has been established Announcement: HERE Announcement of the Minister of Health of February 21, 2022...
On the website of the Ministry of Health, a Draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices has been published, which will enter into force on March 1, 2022. Comments to the draft Notice of the Minister...
Scientists at National Robotarium, a partnership between Heriot-Watt University and Edinburgh University, industrial partners and Edinburgh clinicians are developing a new robotic surgery technique to improve cancer outcomes and patient care . The groundbreaking method has won a £ 1.25 million...
The agenda for the Transparency Council (02/14) includes: Preparation of an opinion on the validity of introducing Vocabria (cabotegravir), used in combination with rilpivirine, into the health policy program "Antiretroviral treatment of people living with HIV in Poland". Preparation of a...
In an interview between Medexpress and professor Marek Wojtukiewicz, head of the Oncology Clinic, Medical University in Białystok, we asked about the unmet needs of patients suffering from pancreatic cancer and about the challenges faced by doctors dealing with this group of oncological patients....
- We will be changing drug programs comprehensively - said Deputy Minister of Health Maciej Miłkowski during the Hearing of the Social Forum of Patients' Organizations and announced further good changes in hemat-oncology.
Sanofi has unveiled a new unified corporate brand. This is the effect of the transformation initiated in December 2019.
Iwona Schymalli's guest is prof. Lidia Gil from the Department and Clinic of Hematology and Bone Marrow Transplantation at the Medical University.
© 2023 Medexpress. All Rights Reserved
